Founded in 2002, Brooks Laboratories Limited is a prominent player in the pharmaceutical industry, engaged in the manufacturing and global marketing of pharmaceutical products. The company operates from its self-owned manufacturing facility situated in Baddi, Himachal Pradesh.
Distinguished by its strong focus on Research and Development, Brooks Laboratories stands as a pharmaceutical manufacturing enterprise that offers a diverse array of solutions to its clientele.
Functioning as a pivotal Pharmaceutical Contract Research and Manufacturing Services provider, Brooks Laboratories is dedicated to catering to the critical care domain, particularly within the Parental Section. Its comprehensive product portfolio encompasses Beta Lactam, Ampoules and Liquid vials, General Dry powder Injectables, Dry Syrups, and Tablets.
The product range encompasses:
- Liquid Injection
- Dry Powder Injection
- Tablets
- Oral Suspension
Fueled by a team of dedicated and highly qualified professionals, the company remains committed to the exploration and stabilization of new molecules in specialized segments. This strategic endeavor ensures the continuous delivery of innovative and stable products to the ultimate beneficiaries – the end customers.
Brooks Laboratories Ltd. Stock Quote #
- Open: ₹98.00
- High – Low: ₹102.65 – ₹95.10
- Previous Close: ₹98.70
- Total Traded Value: 1,30,951
- 52 Weeks High: ₹142.03 (Sep 02, 2022)
- 52 Weeks Low: ₹56.93 (May 25, 2023)
- Updated On: Aug 03, 2023 4:00 PM
Brooks Laboratories Rights Issue 2023 Detail #
| Issue Open | Aug 7, 2023 – Aug 22, 2023 |
| Security Name | Brooks Laboratories Limited |
| Issue Size (Shares) | 1,543,926 |
| Issue Size (Amount) | ₹11.58 Crores |
| Issue Price | ₹75 per share |
| Face Value | ₹10 per share |
| Listing At | BSE, NSE |
| Terms of Payment | Full amount of Rs. 75 for rights equity shares has to be paid on application. |
| Entitlement | 1 Rights Equity Share(s) for every 16 fully paid-up Equity Shares held on Record Date |
Brooks Laboratories Rights Issue 2023 Issue Timetable #
| Last Date to buy shares | Jul 27, 2023 |
| Record Date | Jul 28, 2023 |
| Credit of Rights Entitlements | Aug 3, 2023 |
| Bid/Offer Opens On | Aug 7, 2023 |
| Renunciation of Rights Entitlements | Aug 17, 2023 |
| Bid/Offer Closes On | Aug 22, 2023 |
| Deemed Date of Allotment | Aug 29, 2023 |
| Credit Date | Aug 30, 2023 |
| Listing Date | Sep 1, 2023 |
Company Financials #
| Period Ended | 31 Mar 2022 | 31 Mar 2023 |
| Assets | 195.91 | 109.60 |
| Revenue | 91.99 | 63.41 |
| Profit After Tax | -18.31 | -31.05 |
| Net Worth | ||
| Reserves and Surplus | ||
| Total Borrowing |
Objects of the Issue: #
The company intends to utilize the net proceeds from the issue towards the funding of the following objects:
- Funding the working capital requirements of the company
- General Corporate Purposes
Brooks Laboratories Rights Issue 2023 Documents #
Company Contact Information #
Vill.Kishanpura,
Nalagarh Road,
Baddi – 174101Phone: +91-1795 – 236939
Email: investors@brookslabs.net
Website: https://www.brookslabs.net/
Brooks Laboratories Rights Issue 2023 Registrar #
- Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: brooks.rights2023@linkintime.co.in
Website: https://linkintime.co.in/mipo/ipoallotment.html
